Neutral loss fragmentation pattern based screening for arginine-rich natural products in Xenorhabdus and Photorhabdus SW Fuchs, CC Sachs, C Kegler, FI Nollmann, M Karas, HB Bode Analytical chemistry 84 (16), 6948-6955, 2012 | 59 | 2012 |
Analyzing Microbial Population Heterogeneity-Expanding the Toolbox of Microfluidic Single-Cell Cultivations M Leygeber, D Lindemann, C Sachs, E Kaganovitch, W Wiechert, K Nöh, ... Journal of molecular biology, 2019 | 46 | 2019 |
Image-based single cell profiling: High-throughput processing of mother machine experiments CC Sachs, A Grünberger, S Helfrich, C Probst, W Wiechert, D Kohlheyer, ... PloS one 11 (9), e0163453, 2016 | 41 | 2016 |
Live cell imaging of SOS and prophage dynamics in isogenic bacterial populations S Helfrich, E Pfeifer, C Krämer, CC Sachs, W Wiechert, D Kohlheyer, ... Molecular microbiology 98 (4), 636-650, 2015 | 39 | 2015 |
Germination and Growth Analysis of Streptomyces lividans at the Single-Cell Level Under Varying Medium Compositions J Koepff, CC Sachs, W Wiechert, D Kohlheyer, K Nöh, M Oldiges, ... Frontiers in microbiology 9, 2018 | 10 | 2018 |
Caldariomyces fumago DSM1256 contains two chloroperoxidase genes, both encoding secreted and active enzymes M Buchhaupt, S Hüttmann, CC Sachs, S Bormann, A Hannappel, ... Journal of molecular microbiology and biotechnology 25 (4), 237-243, 2015 | 9 | 2015 |
CellSium: versatile cell simulator for microcolony ground truth generation CC Sachs, K Ruzaeva, J Seiffarth, W Wiechert, B Berkels, K Nöh Bioinformatics Advances 2 (1), vbac053, 2022 | 5 | 2022 |
Growth-rate dependency of ribosome abundance and translation elongation rate in Corynebacterium glutamicum differs from Escherichia coli S Matamouros, T Gensch, M Cerff, CC Sachs, I Abdollahzadeh, ... bioRxiv, 2021.04. 01.438067, 2021 | 3 | 2021 |
mycelyso–high-throughput analysis of Streptomyces mycelium live cell imaging data CC Sachs, J Koepff, W Wiechert, A Grünberger, K Nöh BMC bioinformatics 20 (1), 1-7, 2019 | 3 | 2019 |
583 Quantitative computational assessment of PD-L1 enables robust patient selection for biomarker-informed anti-PD-L1 treatment of NSCLC patients J Lesniak, M Schick, T Kunzke, P Sontakke, T Padel, A Shumilov, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |